Description
Sermorelin, formally designated GHRH(1–29), is a synthetic 29-amino acid polypeptide that corresponds to the N-terminal fragment of endogenous human growth hormone-releasing hormone (GHRH) [5]. This fragment is considered the shortest sequence of GHRH that retains full functional activity at the GHRH receptor, making it a compact and well-defined research tool for studying pituitary signaling dynamics [5].
In preclinical and in vitro research contexts, sermorelin is examined primarily as a growth hormone secretagogue (GHS), a class of compounds that stimulate GH release and downstream IGF-1 signaling [4]. Investigators have used it to probe GHRH receptor activation, pituitary responsiveness, and the cascade of endocrine events that follow receptor engagement. Its inclusion in studies alongside related analogs such as tesamorelin and CJC-1295 has helped researchers map comparative receptor pharmacology and metabolic pathway activity [1], [2].
Sermorelin's relatively small molecular size, defined primary sequence, and well-characterized receptor binding profile make it a useful reference compound in peptide metabolism research. Studies investigating GHRH analog detection have characterized its in vitro metabolite profile and developed sensitive LC-MS/MS methods capable of identifying sermorelin and metabolites such as sermorelin(3–29)-NH₂ at low nanogram-per-milliliter concentrations [3]. This metabolite data supports research into the pharmacokinetic behavior of GHRH-class peptides across experimental systems.
---
References
[1] Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. https://pubmed.ncbi.nlm.nih.gov/41490200/
[2] Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports medicine (Auckland, N.Z.), 2026. https://pubmed.ncbi.nlm.nih.gov/41966639/
[3] Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug testing and analysis, 2021. https://pubmed.ncbi.nlm.nih.gov/34665524/
[4] Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 2020. https://pubmed.ncbi.nlm.nih.gov/32257855/
[5] Sermorelin. Wikipedia. https://en.wikipedia.org/wiki/Sermorelin
